Intermittent preventive antimalarial treatment to children (IPTc): firebreak or fire trap?

Trends in Parasitology

Volumn 24, Issue 11, 2008, Pages 482-485

  Buffet, Pierre A ^a,b,c   Briand, Valérie ^d   Rénia, Laurent ^e   Thellier, Marc ^a,b,c   Danis, Martin ^a,b,c   Mazier, Dominique ^a,b,c  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^e AGENCY FOR SCIENCE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMISININ; ARTESUNATE; FANSIDAR; INSECTICIDE; PLACEBO;

AGRANULOCYTOSIS; BED NET; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG SAFETY; HEPATITIS; HUMAN; MALARIA; PATIENT COMPLIANCE; PREGNANT WOMAN; REBOUND; RISK BENEFIT ANALYSIS; SHORT SURVEY; STEVENS JOHNSON SYNDROME;

AMODIAQUINE; ANTIMALARIALS; ARTEMISININS; CHILD, PRESCHOOL; DECISION MAKING; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; DRUG RESISTANCE; HUMANS; INFANT; MALARIA; PYRIMETHAMINE; SULFADOXINE;

EID: 54849410808     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2008.07.007     Document Type: Short Survey

References (31)

1. Garner, P. and Gulmezoglu, A.M. (2006) Drugs for preventing malaria in pregnant women. Cochrane Database Syst. Rev., CD000169
2. ter Kuile F.O., et al. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. J. Am. Med. Assoc. 297 (2007) 2603-2616
3. Briand V., et al. Intermittent preventive treatment for the prevention of malaria during pregnancy in high transmission areas. Malar. J. 6 (2007) 160
4. Schellenberg D., et al. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. Lancet 357 (2001) 1471-1477
5. Greenwood B. Intermittent preventive antimalarial treatment in infants. Clin. Infect. Dis. 45 (2007) 26-28
6. Barnes K.I., et al. Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS Med. 2 (2005) e330
7. Schellenberg D., et al. The changing epidemiology of malaria in Ifakara Town, southern Tanzania. Trop. Med. Int. Health 9 (2004) 68-76
8. Dicko A., et al. Impact of intermittent preventive treatment with sulfadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children of 6 months to 10 years in Kambila. Mali. Am. J. Trop. Med. Hyg. 71 (2004) 1-79
9. Cisse B., et al. Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial. Lancet 367 (2006) 659-667
10. Robert V., et al. Malaria transmission in the rural zone of Niakhar, Senegal. Trop. Med. Int. Health 3 (1998) 667-677
11. Sokhna C., et al. A trial of the efficacy, safety and impact on drug resistance of four drug regimens for seasonal intermittent preventive treatment for malaria in Senegalese children. PLoS One 3 (2008) e1471
12. Taylor W.R., and White N.J. Antimalarial drug toxicity: a review. Drug Saf. 27 (2004) 25-61
13. Larrey D., et al. Amodiaquine-induced hepatitis. A report of seven cases. Ann. Intern. Med. 104 (1986) 801-803
14. Zitelli B.J., et al. Fatal hepatic necrosis due to pyrimethamine-sulfadoxine (Fansidar). Ann. Intern. Med. 106 (1987) 393-395
15. Gimnig J.E., et al. Severe cutaneous reactions to sulfadoxine-pyrimethamine and trimethoprim-sulfamethoxazole in Blantyre District, Malawi. Am. J. Trop. Med. Hyg. 74 (2006) 738-743
16. Dicko A., et al. Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali. Malar. J. 7 (2008) 123
17. Greenwood B. Review: Intermittent preventive treatment - a new approach to the prevention of malaria in children in areas with seasonal malaria transmission. Trop. Med. Int. Health 11 (2006) 983-991
18. Belnoue E., et al. Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J. Immunol. 172 (2004) 2487-2495
19. Roestenberg M., et al. Induction of protective immunity by experimental malaria infection in humans. Int. J. Parasitol. 38 (2008) S31
20. Schellenberg D., et al. Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial. Lancet 365 (2005) 1481-1483
21. Gosling R.D., et al. Can changes in malaria transmission intensity explain prolonged protection and contribute to high protective efficacy of intermittent preventive treatment for malaria in infants?. Malar. J. 7 (2008) 54
22. Schneider P., et al. (Sub)microscopic Plasmodium falciparum gametocytaemia in Kenyan children after treatment with sulphadoxine-pyrimethamine monotherapy or in combination with artesunate. Int. J. Parasitol. 36 (2006) 403-408
23. O'Meara W.P., et al. Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria. PLoS Med. 3 (2006) e141
24. Alexander N., et al. Modelling the impact of intermittent preventive treatment for malaria on selection pressure for drug resistance. Malar. J. 6 (2007) 9
25. O'Meara W.P., et al. The promise and potential challenges of intermittent preventive treatment for malaria in infants (IPTi). Malar. J. 4 (2005) 33
26. O'Meara W.P., et al. Sources of variability in determining malaria parasite density by microscopy. Am. J. Trop. Med. Hyg. 73 (2005) 593-598
27. Greenwood B.M., et al. Malaria: progress, perils, and prospects for eradication. J. Clin. Invest. 118 (2008) 1266-1276
28. Nosten F., et al. Case management of malaria in pregnancy. Lancet Infect. Dis. 7 (2007) 118-125
29. Schultz L.J., et al. The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. Am. J. Trop. Med. Hyg. 51 (1994) 515-522
30. White N.J. Intermittent presumptive treatment for malaria. PLoS Med. 2 (2005) e3
31. Meremikwu M.M. et al. (2008) Chemoprophylaxis and intermittent treatment for preventing malaria in children. Cochrane Database Syst. Rev., CD003756